

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | facial nerve structural organization (GO:0021612) | 4.74879174 |
| 2 | phospholipid scrambling (GO:0017121) | 4.35535846 |
| 3 | respiratory chain complex IV assembly (GO:0008535) | 4.29455996 |
| 4 | DNA deamination (GO:0045006) | 4.12366170 |
| 5 | GDP-mannose metabolic process (GO:0019673) | 4.10297452 |
| 6 | pattern specification involved in kidney development (GO:0061004) | 4.01033856 |
| 7 | protein heterotetramerization (GO:0051290) | 3.92779977 |
| 8 | platelet dense granule organization (GO:0060155) | 3.92435098 |
| 9 | regulation of metalloenzyme activity (GO:0048552) | 3.88899839 |
| 10 | regulation of pigment cell differentiation (GO:0050932) | 3.84458779 |
| 11 | response to interferon-alpha (GO:0035455) | 3.83067806 |
| 12 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.80187636 |
| 13 | mannosylation (GO:0097502) | 3.80000766 |
| 14 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.68983805 |
| 15 | cytochrome complex assembly (GO:0017004) | 3.60544327 |
| 16 | signal peptide processing (GO:0006465) | 3.60241324 |
| 17 | nephron tubule formation (GO:0072079) | 3.51487131 |
| 18 | paraxial mesoderm development (GO:0048339) | 3.46883620 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.46511624 |
| 20 | negative regulation of metanephros development (GO:0072217) | 3.44327864 |
| 21 | proteasome assembly (GO:0043248) | 3.43796740 |
| 22 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.42149835 |
| 23 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.38451492 |
| 24 | chondrocyte proliferation (GO:0035988) | 3.36320808 |
| 25 | endosome to melanosome transport (GO:0035646) | 3.31539926 |
| 26 | endosome to pigment granule transport (GO:0043485) | 3.31539926 |
| 27 | mature B cell differentiation involved in immune response (GO:0002313) | 3.29398446 |
| 28 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.26491274 |
| 29 | ventricular cardiac muscle cell development (GO:0055015) | 3.24136917 |
| 30 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.22062529 |
| 31 | cranial nerve structural organization (GO:0021604) | 3.20687712 |
| 32 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.18156531 |
| 33 | cranial nerve morphogenesis (GO:0021602) | 3.17493771 |
| 34 | establishment of integrated proviral latency (GO:0075713) | 3.13962268 |
| 35 | cell adhesion mediated by integrin (GO:0033627) | 3.12830196 |
| 36 | peripheral nervous system neuron development (GO:0048935) | 3.12334665 |
| 37 | omega-hydroxylase P450 pathway (GO:0097267) | 3.11973364 |
| 38 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.10205576 |
| 39 | positive regulation of macrophage differentiation (GO:0045651) | 3.08528095 |
| 40 | metanephric nephron tubule development (GO:0072234) | 3.07399928 |
| 41 | metanephric tubule development (GO:0072170) | 3.07399928 |
| 42 | lymphoid progenitor cell differentiation (GO:0002320) | 3.07309522 |
| 43 | membrane invagination (GO:0010324) | 3.07087039 |
| 44 | androgen biosynthetic process (GO:0006702) | 3.04241688 |
| 45 | mesonephros development (GO:0001823) | 3.03090582 |
| 46 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.01617493 |
| 47 | C-terminal protein lipidation (GO:0006501) | 2.96939745 |
| 48 | notochord development (GO:0030903) | 2.93790234 |
| 49 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.91011592 |
| 50 | postsynaptic membrane organization (GO:0001941) | 2.90208567 |
| 51 | response to interferon-beta (GO:0035456) | 2.90085425 |
| 52 | hemidesmosome assembly (GO:0031581) | 2.89749259 |
| 53 | adenosine metabolic process (GO:0046085) | 2.87405456 |
| 54 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.86521124 |
| 55 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.85517526 |
| 56 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 2.83673728 |
| 57 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.79035426 |
| 58 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.77769952 |
| 59 | neurofilament cytoskeleton organization (GO:0060052) | 2.77022956 |
| 60 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.74569736 |
| 61 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.74451839 |
| 62 | GPI anchor biosynthetic process (GO:0006506) | 2.73510712 |
| 63 | regulation of cardioblast differentiation (GO:0051890) | 2.71893548 |
| 64 | endothelial cell morphogenesis (GO:0001886) | 2.71517504 |
| 65 | collagen fibril organization (GO:0030199) | 2.71213831 |
| 66 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.69843075 |
| 67 | axon extension involved in axon guidance (GO:0048846) | 2.69843075 |
| 68 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.67743576 |
| 69 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.65735175 |
| 70 | regulation of interleukin-8 secretion (GO:2000482) | 2.65644441 |
| 71 | metanephric nephron epithelium development (GO:0072243) | 2.65179038 |
| 72 | sympathetic nervous system development (GO:0048485) | 2.64853288 |
| 73 | generation of neurons (GO:0048699) | 2.64774190 |
| 74 | embryonic foregut morphogenesis (GO:0048617) | 2.64239224 |
| 75 | neutrophil activation involved in immune response (GO:0002283) | 2.62532964 |
| 76 | metanephric epithelium development (GO:0072207) | 2.62320492 |
| 77 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.61785683 |
| 78 | response to folic acid (GO:0051593) | 2.61625967 |
| 79 | response to increased oxygen levels (GO:0036296) | 2.61409743 |
| 80 | response to hyperoxia (GO:0055093) | 2.61409743 |
| 81 | urogenital system development (GO:0001655) | 2.59405740 |
| 82 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.58618875 |
| 83 | positive regulation of protein export from nucleus (GO:0046827) | 2.58189243 |
| 84 | mitotic metaphase plate congression (GO:0007080) | 2.57202022 |
| 85 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.55754704 |
| 86 | anterior/posterior axis specification, embryo (GO:0008595) | 2.55581114 |
| 87 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.51966819 |
| 88 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.51922031 |
| 89 | cellular response to vitamin D (GO:0071305) | 2.51388347 |
| 90 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.51275715 |
| 91 | nephron epithelium development (GO:0072009) | 2.50401015 |
| 92 | gap junction assembly (GO:0016264) | 2.50233515 |
| 93 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.50108418 |
| 94 | superoxide anion generation (GO:0042554) | 2.50035314 |
| 95 | ribosomal small subunit assembly (GO:0000028) | 2.49391831 |
| 96 | positive regulation of metanephros development (GO:0072216) | 2.49171712 |
| 97 | endodermal cell differentiation (GO:0035987) | 2.48449573 |
| 98 | C-terminal protein amino acid modification (GO:0018410) | 2.45128172 |
| 99 | mitochondrial calcium ion transport (GO:0006851) | 2.44700203 |
| 100 | viral genome replication (GO:0019079) | 2.44166189 |
| 101 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.43932272 |
| 102 | artery development (GO:0060840) | 2.43580106 |
| 103 | protein localization to kinetochore (GO:0034501) | 2.42237300 |
| 104 | metaphase plate congression (GO:0051310) | 2.42228960 |
| 105 | phagocytosis, engulfment (GO:0006911) | 2.42193609 |
| 106 | cellular response to ATP (GO:0071318) | 2.42043878 |
| 107 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.41946292 |
| 108 | nucleotide-sugar metabolic process (GO:0009225) | 2.40900349 |
| 109 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.40440368 |
| 110 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.40046379 |
| 111 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.39714004 |
| 112 | ribosome assembly (GO:0042255) | 2.39450798 |
| 113 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.39299545 |
| 114 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.38390952 |
| 115 | mature B cell differentiation (GO:0002335) | 2.37938320 |
| 116 | response to peptidoglycan (GO:0032494) | 2.37934565 |
| 117 | regulation of protein heterodimerization activity (GO:0043497) | 2.37531313 |
| 118 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.36481327 |
| 119 | negative regulation of granulocyte differentiation (GO:0030853) | 2.36275426 |
| 120 | positive regulation of protein autophosphorylation (GO:0031954) | 2.36142942 |
| 121 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.36063305 |
| 122 | endothelium development (GO:0003158) | 2.35959660 |
| 123 | nucleoside diphosphate catabolic process (GO:0009134) | 2.35727155 |
| 124 | skin morphogenesis (GO:0043589) | 2.35470426 |
| 125 | COPII vesicle coating (GO:0048208) | 2.35460223 |
| 126 | lymphangiogenesis (GO:0001946) | 2.35394226 |
| 127 | desmosome organization (GO:0002934) | 2.34936413 |
| 128 | establishment of viral latency (GO:0019043) | 2.34828676 |
| 129 | Golgi transport vesicle coating (GO:0048200) | 2.34654520 |
| 130 | COPI coating of Golgi vesicle (GO:0048205) | 2.34654520 |
| 131 | hippo signaling (GO:0035329) | 2.34485641 |
| 132 | kidney mesenchyme development (GO:0072074) | 2.33473290 |
| 133 | behavioral response to pain (GO:0048266) | 2.33031841 |
| 134 | ganglion development (GO:0061548) | 2.31721327 |
| 135 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.31425898 |
| 136 | CENP-A containing nucleosome assembly (GO:0034080) | 2.31204191 |
| 137 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.30938939 |
| 138 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.30384579 |
| 139 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.30198485 |
| 140 | L-fucose catabolic process (GO:0042355) | 2.29435091 |
| 141 | fucose catabolic process (GO:0019317) | 2.29435091 |
| 142 | L-fucose metabolic process (GO:0042354) | 2.29435091 |
| 143 | cytokine production involved in immune response (GO:0002367) | 2.29141283 |
| 144 | daunorubicin metabolic process (GO:0044597) | 2.28968043 |
| 145 | doxorubicin metabolic process (GO:0044598) | 2.28968043 |
| 146 | peptidyl-proline hydroxylation (GO:0019511) | 2.28121860 |
| 147 | chromatin remodeling at centromere (GO:0031055) | 2.28049448 |
| 148 | regulation of keratinocyte proliferation (GO:0010837) | 2.27577253 |
| 149 | cellular response to vitamin (GO:0071295) | 2.26339611 |
| 150 | negative regulation of stem cell proliferation (GO:2000647) | 2.25993844 |
| 151 | positive regulation of actin filament depolymerization (GO:0030836) | 2.25713959 |
| 152 | negative regulation of axon guidance (GO:1902668) | 2.24744788 |
| 153 | response to X-ray (GO:0010165) | 2.24660357 |
| 154 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.23178368 |
| 155 | type B pancreatic cell proliferation (GO:0044342) | 2.23165833 |
| 156 | mitotic cytokinesis (GO:0000281) | 2.21775461 |
| 157 | negative chemotaxis (GO:0050919) | 2.20246105 |
| 158 | regulation of mitotic spindle organization (GO:0060236) | 2.18930283 |
| 159 | muscle cell migration (GO:0014812) | 2.14393930 |
| 160 | membrane assembly (GO:0071709) | 2.13878889 |
| 161 | outer ear morphogenesis (GO:0042473) | 2.13291187 |
| 162 | response to redox state (GO:0051775) | 2.12830960 |
| 163 | wound healing, spreading of epidermal cells (GO:0035313) | 2.12484480 |
| 164 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.11290112 |
| 165 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.10822438 |
| 166 | protein localization to cell surface (GO:0034394) | 2.10671015 |
| 167 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.10629400 |
| 168 | protein heterotrimerization (GO:0070208) | 2.10601588 |
| 169 | dorsal/ventral axis specification (GO:0009950) | 2.10474547 |
| 170 | protein retention in ER lumen (GO:0006621) | 2.06411667 |
| 171 | midgut development (GO:0007494) | 2.05275703 |
| 172 | substrate-dependent cell migration (GO:0006929) | 2.03818090 |
| 173 | female gonad development (GO:0008585) | 2.03101851 |
| 174 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.02838524 |
| 175 | metanephric mesenchyme development (GO:0072075) | 2.02723188 |
| 176 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.02499292 |
| 177 | protein hydroxylation (GO:0018126) | 2.02168536 |
| 178 | protein maturation by protein folding (GO:0022417) | 2.01433711 |
| 179 | mitotic sister chromatid segregation (GO:0000070) | 2.01247203 |
| 180 | craniofacial suture morphogenesis (GO:0097094) | 2.00851409 |
| 181 | establishment of chromosome localization (GO:0051303) | 2.00408149 |
| 182 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 1.99250499 |
| 183 | regulation of spindle organization (GO:0090224) | 1.98279651 |
| 184 | bone trabecula formation (GO:0060346) | 1.97793054 |
| 185 | regulation of axon guidance (GO:1902667) | 1.96641828 |
| 186 | membrane budding (GO:0006900) | 1.96602587 |
| 187 | establishment of planar polarity (GO:0001736) | 1.96299132 |
| 188 | establishment of tissue polarity (GO:0007164) | 1.96299132 |
| 189 | regulation of axon extension involved in axon guidance (GO:0048841) | 1.96166986 |
| 190 | regulation of cell fate specification (GO:0042659) | 1.96013977 |
| 191 | keratinocyte proliferation (GO:0043616) | 1.94925802 |
| 192 | spindle checkpoint (GO:0031577) | 1.94883435 |
| 193 | regulation of heart morphogenesis (GO:2000826) | 1.94323410 |
| 194 | histone exchange (GO:0043486) | 1.94055377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.64920966 |
| 2 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.12335117 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.87369850 |
| 4 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.72685730 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72137259 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67526345 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.64874229 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.59350993 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.49052400 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.47877054 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.47799087 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.40585381 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.35427033 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31641715 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21230809 |
| 16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.14785128 |
| 17 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.11419354 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08538163 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06720266 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.02834068 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02767512 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02676034 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.99593410 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96842891 |
| 25 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.96029645 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94085354 |
| 27 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.90506894 |
| 28 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87189318 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.79701046 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78866175 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78072290 |
| 32 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.76508228 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.74645163 |
| 34 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.71106660 |
| 35 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.71045286 |
| 36 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.70480257 |
| 37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.66358965 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.66154057 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.63855877 |
| 40 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.62889449 |
| 41 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.62661236 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61698378 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60601204 |
| 44 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.60421741 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59904124 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58930129 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.57954696 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57641713 |
| 49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.57293705 |
| 50 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56672615 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.56539031 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54218165 |
| 53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53135835 |
| 54 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.52788732 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.52659892 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51152505 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51026590 |
| 58 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.50438602 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.49684219 |
| 60 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.48832548 |
| 61 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.48327486 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47848526 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.47308755 |
| 64 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.46182362 |
| 65 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45906179 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44680642 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44680642 |
| 68 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.43356964 |
| 69 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.42879555 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41392371 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40991180 |
| 72 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40347193 |
| 73 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.39229286 |
| 74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39146738 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39141048 |
| 76 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.38740088 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38489995 |
| 78 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37576489 |
| 79 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.36918414 |
| 80 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.36070533 |
| 81 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35808109 |
| 82 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34249340 |
| 83 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34246547 |
| 84 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32593759 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32531957 |
| 86 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.31361242 |
| 87 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.31361242 |
| 88 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.30701508 |
| 89 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30658255 |
| 90 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.28809647 |
| 91 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.27819979 |
| 92 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.26602062 |
| 93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.26465991 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26319611 |
| 95 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.25739608 |
| 96 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.25609940 |
| 97 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25565326 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25347655 |
| 99 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24004392 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23132977 |
| 101 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22755978 |
| 102 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.20849983 |
| 103 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20523491 |
| 104 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20432853 |
| 105 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.19178725 |
| 106 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.19058121 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18986247 |
| 108 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18798140 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18629509 |
| 110 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.17389290 |
| 111 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.16628309 |
| 112 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16060039 |
| 113 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15903308 |
| 114 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15279836 |
| 115 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.15041748 |
| 116 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14765528 |
| 117 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14253968 |
| 118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13604271 |
| 119 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13370143 |
| 120 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.12830385 |
| 121 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12023488 |
| 122 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11383045 |
| 123 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.11364480 |
| 124 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11011385 |
| 125 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.10937239 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10480309 |
| 127 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09925781 |
| 128 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.09774635 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.09491210 |
| 130 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09221216 |
| 131 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08056536 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07746808 |
| 133 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07594349 |
| 134 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06762257 |
| 135 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06679882 |
| 136 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06401896 |
| 137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06337202 |
| 138 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05526433 |
| 139 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04903510 |
| 140 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04686880 |
| 141 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.04655559 |
| 142 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04459632 |
| 143 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03626373 |
| 144 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.03488488 |
| 145 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.02666179 |
| 146 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01323806 |
| 147 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01269906 |
| 148 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01023436 |
| 149 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.01007133 |
| 150 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.00946671 |
| 151 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.00632876 |
| 152 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00325613 |
| 153 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.99945833 |
| 154 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99120997 |
| 155 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99102304 |
| 156 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.98819357 |
| 157 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98730744 |
| 158 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.98287309 |
| 159 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.97954230 |
| 160 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95231697 |
| 161 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95126762 |
| 162 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94976883 |
| 163 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.94613069 |
| 164 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.92906612 |
| 165 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88418260 |
| 166 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88306955 |
| 167 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.86607725 |
| 168 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.86029210 |
| 169 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.85451491 |
| 170 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.85265460 |
| 171 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84840014 |
| 172 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.84078352 |
| 173 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.83932765 |
| 174 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82703234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 5.19231103 |
| 2 | MP0001188_hyperpigmentation | 3.71419674 |
| 3 | MP0001986_abnormal_taste_sensitivity | 3.50195230 |
| 4 | MP0003941_abnormal_skin_development | 3.31114069 |
| 5 | MP0003724_increased_susceptibility_to | 3.08158781 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.91824149 |
| 7 | MP0005174_abnormal_tail_pigmentation | 2.90910329 |
| 8 | MP0000015_abnormal_ear_pigmentation | 2.79846227 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.67915928 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.66107722 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.55583773 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.41818963 |
| 13 | MP0005623_abnormal_meninges_morphology | 2.38185480 |
| 14 | MP0005409_darkened_coat_color | 2.36218082 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.32140432 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.27346377 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.26362320 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.14020967 |
| 19 | MP0001958_emphysema | 2.07029836 |
| 20 | MP0009785_altered_susceptibility_to | 2.05396758 |
| 21 | MP0000681_abnormal_thyroid_gland | 2.04899871 |
| 22 | MP0003566_abnormal_cell_adhesion | 2.01904267 |
| 23 | MP0009697_abnormal_copulation | 1.99692965 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 1.97562836 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.97288573 |
| 26 | MP0005275_abnormal_skin_tensile | 1.90420108 |
| 27 | MP0000762_abnormal_tongue_morphology | 1.90182695 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.87914800 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.85329435 |
| 30 | MP0008260_abnormal_autophagy | 1.84262031 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.83137892 |
| 32 | MP0001542_abnormal_bone_strength | 1.82628867 |
| 33 | MP0004381_abnormal_hair_follicle | 1.79658890 |
| 34 | MP0000537_abnormal_urethra_morphology | 1.78509127 |
| 35 | MP0001299_abnormal_eye_distance/ | 1.78502990 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.76258473 |
| 37 | MP0003937_abnormal_limbs/digits/tail_de | 1.76093650 |
| 38 | MP0009053_abnormal_anal_canal | 1.75197815 |
| 39 | MP0002736_abnormal_nociception_after | 1.71622943 |
| 40 | MP0003136_yellow_coat_color | 1.70402026 |
| 41 | MP0000490_abnormal_crypts_of | 1.68483950 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.64034743 |
| 43 | MP0003283_abnormal_digestive_organ | 1.61258284 |
| 44 | MP0003436_decreased_susceptibility_to | 1.57736326 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.57296043 |
| 46 | MP0008932_abnormal_embryonic_tissue | 1.56048245 |
| 47 | MP0003279_aneurysm | 1.55280000 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.54513304 |
| 49 | MP0002233_abnormal_nose_morphology | 1.54074606 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.53835497 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.53147408 |
| 52 | MP0001879_abnormal_lymphatic_vessel | 1.49292197 |
| 53 | MP0002095_abnormal_skin_pigmentation | 1.46987194 |
| 54 | MP0004957_abnormal_blastocyst_morpholog | 1.46910705 |
| 55 | MP0003868_abnormal_feces_composition | 1.45132488 |
| 56 | MP0006054_spinal_hemorrhage | 1.44633040 |
| 57 | MP0003755_abnormal_palate_morphology | 1.42878188 |
| 58 | MP0009384_cardiac_valve_regurgitation | 1.42225993 |
| 59 | MP0002697_abnormal_eye_size | 1.40246896 |
| 60 | MP0003385_abnormal_body_wall | 1.38124644 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.37637445 |
| 62 | MP0002751_abnormal_autonomic_nervous | 1.36586759 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.35532191 |
| 64 | MP0008004_abnormal_stomach_pH | 1.34371239 |
| 65 | MP0002177_abnormal_outer_ear | 1.31686751 |
| 66 | MP0005025_abnormal_response_to | 1.30969985 |
| 67 | MP0000516_abnormal_urinary_system | 1.30622643 |
| 68 | MP0005367_renal/urinary_system_phenotyp | 1.30622643 |
| 69 | MP0005171_absent_coat_pigmentation | 1.29834255 |
| 70 | MP0000534_abnormal_ureter_morphology | 1.29208530 |
| 71 | MP0004147_increased_porphyrin_level | 1.28769954 |
| 72 | MP0002419_abnormal_innate_immunity | 1.28183283 |
| 73 | MP0006292_abnormal_olfactory_placode | 1.28138748 |
| 74 | MP0005023_abnormal_wound_healing | 1.27361149 |
| 75 | MP0001293_anophthalmia | 1.27188957 |
| 76 | MP0002234_abnormal_pharynx_morphology | 1.26984277 |
| 77 | MP0004272_abnormal_basement_membrane | 1.23413878 |
| 78 | MP0003119_abnormal_digestive_system | 1.23367386 |
| 79 | MP0005257_abnormal_intraocular_pressure | 1.23050021 |
| 80 | MP0009764_decreased_sensitivity_to | 1.22312034 |
| 81 | MP0000428_abnormal_craniofacial_morphol | 1.21846819 |
| 82 | MP0003890_abnormal_embryonic-extraembry | 1.19412452 |
| 83 | MP0000566_synostosis | 1.18653611 |
| 84 | MP0003935_abnormal_craniofacial_develop | 1.16795425 |
| 85 | MP0001533_abnormal_skeleton_physiology | 1.16623508 |
| 86 | MP0003186_abnormal_redox_activity | 1.15384772 |
| 87 | MP0005408_hypopigmentation | 1.15301064 |
| 88 | MP0002998_abnormal_bone_remodeling | 1.14331473 |
| 89 | MP0000462_abnormal_digestive_system | 1.14212296 |
| 90 | MP0002396_abnormal_hematopoietic_system | 1.13526796 |
| 91 | MP0000467_abnormal_esophagus_morphology | 1.13333667 |
| 92 | MP0002084_abnormal_developmental_patter | 1.13223569 |
| 93 | MP0000751_myopathy | 1.12494328 |
| 94 | MP0005464_abnormal_platelet_physiology | 1.12433701 |
| 95 | MP0001853_heart_inflammation | 1.12382343 |
| 96 | MP0003693_abnormal_embryo_hatching | 1.12220462 |
| 97 | MP0005508_abnormal_skeleton_morphology | 1.10513618 |
| 98 | MP0003942_abnormal_urinary_system | 1.10026519 |
| 99 | MP0002282_abnormal_trachea_morphology | 1.09571801 |
| 100 | MP0000749_muscle_degeneration | 1.09247059 |
| 101 | MP0000767_abnormal_smooth_muscle | 1.08357928 |
| 102 | MP0005000_abnormal_immune_tolerance | 1.06972017 |
| 103 | MP0002896_abnormal_bone_mineralization | 1.06762536 |
| 104 | MP0002132_abnormal_respiratory_system | 1.06302616 |
| 105 | MP0002085_abnormal_embryonic_tissue | 1.05738962 |
| 106 | MP0000432_abnormal_head_morphology | 1.04475643 |
| 107 | MP0003111_abnormal_nucleus_morphology | 1.03328476 |
| 108 | MP0000613_abnormal_salivary_gland | 1.01158238 |
| 109 | MP0010155_abnormal_intestine_physiology | 1.00989727 |
| 110 | MP0001286_abnormal_eye_development | 1.00988185 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 1.00838382 |
| 112 | MP0002933_joint_inflammation | 0.99204240 |
| 113 | MP0005197_abnormal_uvea_morphology | 0.99177054 |
| 114 | MP0005360_urolithiasis | 0.98821244 |
| 115 | MP0002102_abnormal_ear_morphology | 0.98618050 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.96659538 |
| 117 | MP0003077_abnormal_cell_cycle | 0.96022766 |
| 118 | MP0008007_abnormal_cellular_replicative | 0.94904763 |
| 119 | MP0001243_abnormal_dermal_layer | 0.92589855 |
| 120 | MP0005390_skeleton_phenotype | 0.92246846 |
| 121 | MP0005671_abnormal_response_to | 0.91032552 |
| 122 | MP0002877_abnormal_melanocyte_morpholog | 0.90961451 |
| 123 | MP0005187_abnormal_penis_morphology | 0.89723677 |
| 124 | MP0003011_delayed_dark_adaptation | 0.89673400 |
| 125 | MP0003879_abnormal_hair_cell | 0.89250518 |
| 126 | MP0002111_abnormal_tail_morphology | 0.88690471 |
| 127 | MP0000579_abnormal_nail_morphology | 0.88218296 |
| 128 | MP0008469_abnormal_protein_level | 0.87361838 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.86989767 |
| 130 | MP0002108_abnormal_muscle_morphology | 0.86906306 |
| 131 | MP0010094_abnormal_chromosome_stability | 0.86395654 |
| 132 | MP0001849_ear_inflammation | 0.86112730 |
| 133 | MP0002092_abnormal_eye_morphology | 0.86068925 |
| 134 | MP0000685_abnormal_immune_system | 0.84094851 |
| 135 | MP0002295_abnormal_pulmonary_circulatio | 0.83763437 |
| 136 | MP0001845_abnormal_inflammatory_respons | 0.83613993 |
| 137 | MP0005595_abnormal_vascular_smooth | 0.83471335 |
| 138 | MP0002938_white_spotting | 0.83037107 |
| 139 | MP0000049_abnormal_middle_ear | 0.82945527 |
| 140 | MP0003315_abnormal_perineum_morphology | 0.82724784 |
| 141 | MP0002932_abnormal_joint_morphology | 0.82547947 |
| 142 | MP0000647_abnormal_sebaceous_gland | 0.82361680 |
| 143 | MP0001672_abnormal_embryogenesis/_devel | 0.82202328 |
| 144 | MP0005380_embryogenesis_phenotype | 0.82202328 |
| 145 | MP0009250_abnormal_appendicular_skeleto | 0.81977158 |
| 146 | MP0001730_embryonic_growth_arrest | 0.81891105 |
| 147 | MP0001270_distended_abdomen | 0.80957266 |
| 148 | MP0000733_abnormal_muscle_development | 0.80910587 |
| 149 | MP0002060_abnormal_skin_morphology | 0.80327724 |
| 150 | MP0002723_abnormal_immune_serum | 0.80066416 |
| 151 | MP0003718_maternal_effect | 0.79947363 |
| 152 | MP0000858_altered_metastatic_potential | 0.78989555 |
| 153 | MP0003091_abnormal_cell_migration | 0.78183207 |
| 154 | MP0005165_increased_susceptibility_to | 0.78019500 |
| 155 | MP0001663_abnormal_digestive_system | 0.77157309 |
| 156 | MP0001186_pigmentation_phenotype | 0.77122195 |
| 157 | MP0002116_abnormal_craniofacial_bone | 0.76877161 |
| 158 | MP0003115_abnormal_respiratory_system | 0.76554959 |
| 159 | MP0000163_abnormal_cartilage_morphology | 0.76064231 |
| 160 | MP0002166_altered_tumor_susceptibility | 0.75583754 |
| 161 | MP0005193_abnormal_anterior_eye | 0.74029910 |
| 162 | MP0010386_abnormal_urinary_bladder | 0.73864734 |
| 163 | MP0002452_abnormal_antigen_presenting | 0.73789093 |
| 164 | MP0002006_tumorigenesis | 0.73751168 |
| 165 | MP0003984_embryonic_growth_retardation | 0.73562274 |
| 166 | MP0005636_abnormal_mineral_homeostasis | 0.73328353 |
| 167 | MP0001697_abnormal_embryo_size | 0.73208969 |
| 168 | MP0002160_abnormal_reproductive_system | 0.73106021 |
| 169 | MP0002163_abnormal_gland_morphology | 0.72563369 |
| 170 | MP0002138_abnormal_hepatobiliary_system | 0.72325109 |
| 171 | MP0000343_altered_response_to | 0.71971890 |
| 172 | MP0002088_abnormal_embryonic_growth/wei | 0.71189550 |
| 173 | MP0005501_abnormal_skin_physiology | 0.70778653 |
| 174 | MP0004019_abnormal_vitamin_homeostasis | 0.70056299 |
| 175 | MP0003795_abnormal_bone_structure | 0.70027741 |
| 176 | MP0001915_intracranial_hemorrhage | 0.69718143 |
| 177 | MP0002405_respiratory_system_inflammati | 0.69657557 |
| 178 | MP0002109_abnormal_limb_morphology | 0.69441881 |
| 179 | MP0000678_abnormal_parathyroid_gland | 0.69394446 |
| 180 | MP0002420_abnormal_adaptive_immunity | 0.69286448 |
| 181 | MP0002114_abnormal_axial_skeleton | 0.69233955 |
| 182 | MP0001819_abnormal_immune_cell | 0.69153178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 7.54805209 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 6.83908614 |
| 3 | Hypothermia (HP:0002045) | 5.50460178 |
| 4 | Abnormal protein glycosylation (HP:0012346) | 5.07006814 |
| 5 | Abnormal glycosylation (HP:0012345) | 5.07006814 |
| 6 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 5.07006814 |
| 7 | Abnormal protein N-linked glycosylation (HP:0012347) | 5.07006814 |
| 8 | Abnormality of magnesium homeostasis (HP:0004921) | 4.09377109 |
| 9 | Thyroid-stimulating hormone excess (HP:0002925) | 3.80625718 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 3.56370070 |
| 11 | Vascular tortuosity (HP:0004948) | 3.22313358 |
| 12 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.00641747 |
| 13 | Arterial tortuosity (HP:0005116) | 3.00367127 |
| 14 | Hypomagnesemia (HP:0002917) | 2.99766613 |
| 15 | Renal Fanconi syndrome (HP:0001994) | 2.87824987 |
| 16 | Increased hepatocellular lipid droplets (HP:0006565) | 2.87783479 |
| 17 | Protrusio acetabuli (HP:0003179) | 2.83258222 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.82697926 |
| 19 | Ulnar claw (HP:0001178) | 2.80994157 |
| 20 | Follicular hyperkeratosis (HP:0007502) | 2.79617669 |
| 21 | Premature rupture of membranes (HP:0001788) | 2.77922231 |
| 22 | Vertebral compression fractures (HP:0002953) | 2.77760216 |
| 23 | Knee flexion contracture (HP:0006380) | 2.75602646 |
| 24 | Bradycardia (HP:0001662) | 2.74627669 |
| 25 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.70685301 |
| 26 | Ankle contracture (HP:0006466) | 2.61881326 |
| 27 | Nonprogressive disorder (HP:0003680) | 2.58769202 |
| 28 | Neonatal short-limb short stature (HP:0008921) | 2.58479908 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.57632114 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56065668 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.55940100 |
| 32 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.51445629 |
| 33 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.51445629 |
| 34 | Single umbilical artery (HP:0001195) | 2.51445629 |
| 35 | Coronal craniosynostosis (HP:0004440) | 2.50459890 |
| 36 | Exertional dyspnea (HP:0002875) | 2.48667834 |
| 37 | Biconcave vertebral bodies (HP:0004586) | 2.48465782 |
| 38 | Beaking of vertebral bodies (HP:0004568) | 2.45346261 |
| 39 | Aortic aneurysm (HP:0004942) | 2.44112665 |
| 40 | Abnormality of the umbilical cord (HP:0010881) | 2.43956652 |
| 41 | Abnormality of renal resorption (HP:0011038) | 2.41846241 |
| 42 | Pterygium (HP:0001059) | 2.33101937 |
| 43 | Short nail (HP:0001799) | 2.28754310 |
| 44 | Metaphyseal dysplasia (HP:0100255) | 2.28109951 |
| 45 | Thoracic kyphosis (HP:0002942) | 2.27239332 |
| 46 | Shallow orbits (HP:0000586) | 2.24863381 |
| 47 | Bladder diverticulum (HP:0000015) | 2.24736199 |
| 48 | Breech presentation (HP:0001623) | 2.23965242 |
| 49 | Increased intramyocellular lipid droplets (HP:0012240) | 2.21723397 |
| 50 | Peritonitis (HP:0002586) | 2.19839108 |
| 51 | Cervical subluxation (HP:0003308) | 2.17516602 |
| 52 | Atrophic scars (HP:0001075) | 2.17409912 |
| 53 | Abnormal delivery (HP:0001787) | 2.15367151 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 2.14971411 |
| 55 | Glycosuria (HP:0003076) | 2.14971411 |
| 56 | Renal tubular dysfunction (HP:0000124) | 2.14583282 |
| 57 | Microglossia (HP:0000171) | 2.13629213 |
| 58 | Severe visual impairment (HP:0001141) | 2.13391502 |
| 59 | Generalized aminoaciduria (HP:0002909) | 2.13065526 |
| 60 | Hepatic necrosis (HP:0002605) | 2.07674814 |
| 61 | Wormian bones (HP:0002645) | 2.07032582 |
| 62 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.06624474 |
| 63 | Spinal rigidity (HP:0003306) | 2.05637034 |
| 64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04600886 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.04600886 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.04541480 |
| 67 | Abnormal number of erythroid precursors (HP:0012131) | 2.03427634 |
| 68 | Myositis (HP:0100614) | 2.03257168 |
| 69 | Increased corneal curvature (HP:0100692) | 2.02341371 |
| 70 | Keratoconus (HP:0000563) | 2.02341371 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.02191469 |
| 72 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.01535002 |
| 73 | Petechiae (HP:0000967) | 1.99880320 |
| 74 | Type 2 muscle fiber atrophy (HP:0003554) | 1.99041206 |
| 75 | Delayed gross motor development (HP:0002194) | 1.99034172 |
| 76 | Aplastic anemia (HP:0001915) | 1.98786572 |
| 77 | Abnormality of the prostate (HP:0008775) | 1.97974721 |
| 78 | Fragile skin (HP:0001030) | 1.96997905 |
| 79 | Hypoplastic pelvis (HP:0008839) | 1.96530747 |
| 80 | Bowel diverticulosis (HP:0005222) | 1.96232703 |
| 81 | Broad metatarsal (HP:0001783) | 1.95046543 |
| 82 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.89696454 |
| 83 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.89696454 |
| 84 | Thrombocytosis (HP:0001894) | 1.88888823 |
| 85 | Increased muscle lipid content (HP:0009058) | 1.84853959 |
| 86 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83823745 |
| 87 | Hyperphosphaturia (HP:0003109) | 1.83063979 |
| 88 | Patchy hypopigmentation of hair (HP:0011365) | 1.81214393 |
| 89 | Reticulocytopenia (HP:0001896) | 1.80696437 |
| 90 | Microvesicular hepatic steatosis (HP:0001414) | 1.80408371 |
| 91 | Soft skin (HP:0000977) | 1.80041333 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 1.78236042 |
| 93 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78216929 |
| 94 | Respiratory distress (HP:0002098) | 1.76959075 |
| 95 | Spastic diplegia (HP:0001264) | 1.75937610 |
| 96 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.75434708 |
| 97 | Azoospermia (HP:0000027) | 1.75213133 |
| 98 | Lower limb hyperreflexia (HP:0002395) | 1.74608837 |
| 99 | Limited hip movement (HP:0008800) | 1.72192168 |
| 100 | Proximal tubulopathy (HP:0000114) | 1.72030708 |
| 101 | Anhidrosis (HP:0000970) | 1.70976146 |
| 102 | Natal tooth (HP:0000695) | 1.70282370 |
| 103 | Recurrent abscess formation (HP:0002722) | 1.70204978 |
| 104 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.69693250 |
| 105 | Cortical visual impairment (HP:0100704) | 1.69612960 |
| 106 | Muscle fiber atrophy (HP:0100295) | 1.69565791 |
| 107 | Abnormal urine phosphate concentration (HP:0012599) | 1.67821055 |
| 108 | Respiratory difficulties (HP:0002880) | 1.67769365 |
| 109 | Broad face (HP:0000283) | 1.65655506 |
| 110 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.65278916 |
| 111 | Aortic dissection (HP:0002647) | 1.65121345 |
| 112 | Prolonged bleeding time (HP:0003010) | 1.64940078 |
| 113 | Hypoglycemic seizures (HP:0002173) | 1.64421393 |
| 114 | Hyperparathyroidism (HP:0000843) | 1.64385491 |
| 115 | Hyperactive renin-angiotensin system (HP:0000841) | 1.64087885 |
| 116 | Capillary hemangiomas (HP:0005306) | 1.62977223 |
| 117 | Bifid tongue (HP:0010297) | 1.62620837 |
| 118 | Blue sclerae (HP:0000592) | 1.62500326 |
| 119 | Adrenal hypoplasia (HP:0000835) | 1.62006439 |
| 120 | Upper limb muscle weakness (HP:0003484) | 1.61988517 |
| 121 | Episodic fever (HP:0001954) | 1.61937320 |
| 122 | Abnormality of dentin (HP:0010299) | 1.60558697 |
| 123 | Intrahepatic cholestasis (HP:0001406) | 1.60370408 |
| 124 | Hyperphosphatemia (HP:0002905) | 1.59795759 |
| 125 | Pulmonary fibrosis (HP:0002206) | 1.58905566 |
| 126 | Septo-optic dysplasia (HP:0100842) | 1.58516277 |
| 127 | Overgrowth (HP:0001548) | 1.58492677 |
| 128 | Poor head control (HP:0002421) | 1.58413802 |
| 129 | Distal lower limb muscle weakness (HP:0009053) | 1.58353386 |
| 130 | Joint hemorrhage (HP:0005261) | 1.57599206 |
| 131 | Vascular calcification (HP:0004934) | 1.56982989 |
| 132 | Interstitial pulmonary disease (HP:0006530) | 1.56922019 |
| 133 | Spinal cord compression (HP:0002176) | 1.56206089 |
| 134 | Biliary tract neoplasm (HP:0100574) | 1.56030490 |
| 135 | Retinal dysplasia (HP:0007973) | 1.55568728 |
| 136 | Absent frontal sinuses (HP:0002688) | 1.54410457 |
| 137 | True hermaphroditism (HP:0010459) | 1.54351801 |
| 138 | Epistaxis (HP:0000421) | 1.54316824 |
| 139 | Facial cleft (HP:0002006) | 1.53921598 |
| 140 | Microcytic anemia (HP:0001935) | 1.53508553 |
| 141 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.52104873 |
| 142 | Wrist flexion contracture (HP:0001239) | 1.52066084 |
| 143 | Limb-girdle muscle weakness (HP:0003325) | 1.52008891 |
| 144 | Genu recurvatum (HP:0002816) | 1.51140240 |
| 145 | Spinal canal stenosis (HP:0003416) | 1.51030026 |
| 146 | Abnormality of the acetabulum (HP:0003170) | 1.50632257 |
| 147 | Tubulointerstitial nephritis (HP:0001970) | 1.50344973 |
| 148 | Mitochondrial inheritance (HP:0001427) | 1.50321443 |
| 149 | Menorrhagia (HP:0000132) | 1.49253016 |
| 150 | Limb-girdle muscle atrophy (HP:0003797) | 1.49024182 |
| 151 | Abnormality of methionine metabolism (HP:0010901) | 1.48404456 |
| 152 | Abnormal biliary tract morphology (HP:0012440) | 1.47057888 |
| 153 | Joint laxity (HP:0001388) | 1.46116308 |
| 154 | Vertebral clefting (HP:0008428) | 1.44537927 |
| 155 | Hyperextensible skin (HP:0000974) | 1.44397491 |
| 156 | Delayed cranial suture closure (HP:0000270) | 1.43788190 |
| 157 | Protruding ear (HP:0000411) | 1.43752139 |
| 158 | Abnormality of carpal bone ossification (HP:0006257) | 1.43232380 |
| 159 | Popliteal pterygium (HP:0009756) | 1.42467916 |
| 160 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.42073687 |
| 161 | Neoplasm of the rectum (HP:0100743) | 1.41985234 |
| 162 | Abnormality of proline metabolism (HP:0010907) | 1.40130471 |
| 163 | Hydroxyprolinuria (HP:0003080) | 1.40130471 |
| 164 | Meckel diverticulum (HP:0002245) | 1.38937965 |
| 165 | Absent eyelashes (HP:0000561) | 1.38568675 |
| 166 | Mitral valve prolapse (HP:0001634) | 1.36733329 |
| 167 | Increased nuchal translucency (HP:0010880) | 1.36051543 |
| 168 | Slender build (HP:0001533) | 1.34349033 |
| 169 | Pulmonic stenosis (HP:0001642) | 1.33896895 |
| 170 | Deviation of the hallux (HP:0010051) | 1.33516477 |
| 171 | Occipital encephalocele (HP:0002085) | 1.33491197 |
| 172 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.33289945 |
| 173 | Vertebral hypoplasia (HP:0008417) | 1.33258306 |
| 174 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.33258306 |
| 175 | Aortic regurgitation (HP:0001659) | 1.33044701 |
| 176 | Symptomatic seizures (HP:0011145) | 1.32647863 |
| 177 | Dental crowding (HP:0000678) | 1.31986634 |
| 178 | Myelomeningocele (HP:0002475) | 1.31623330 |
| 179 | Astrocytoma (HP:0009592) | 1.31286771 |
| 180 | Abnormality of the astrocytes (HP:0100707) | 1.31286771 |
| 181 | Hypoglycemic coma (HP:0001325) | 1.31125095 |
| 182 | Hip contracture (HP:0003273) | 1.30899526 |
| 183 | Preaxial foot polydactyly (HP:0001841) | 1.29428849 |
| 184 | Neoplasm of the small intestine (HP:0100833) | 1.28767629 |
| 185 | Abnormality of the ileum (HP:0001549) | 1.28218037 |
| 186 | Absent eyebrow (HP:0002223) | 1.27755129 |
| 187 | Colon cancer (HP:0003003) | 1.26905264 |
| 188 | Generalized amyotrophy (HP:0003700) | 1.26542703 |
| 189 | Inguinal hernia (HP:0000023) | 1.26480963 |
| 190 | Ulnar bowing (HP:0003031) | 1.26027180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 7.02959337 |
| 2 | EIF2AK3 | 4.45056107 |
| 3 | NME2 | 3.24390535 |
| 4 | STK16 | 3.15607532 |
| 5 | NLK | 3.02982843 |
| 6 | MUSK | 3.02413424 |
| 7 | BUB1 | 2.81332584 |
| 8 | CASK | 2.76813883 |
| 9 | CAMKK2 | 2.56788904 |
| 10 | PIM2 | 2.32145099 |
| 11 | IRAK3 | 2.29350240 |
| 12 | NEK1 | 2.15182588 |
| 13 | MKNK2 | 2.10931700 |
| 14 | EPHA2 | 2.10341224 |
| 15 | EIF2AK2 | 2.07065206 |
| 16 | MET | 2.04554881 |
| 17 | TTK | 2.00053038 |
| 18 | IRAK4 | 1.94481421 |
| 19 | ERBB4 | 1.93544904 |
| 20 | PAK4 | 1.90374754 |
| 21 | TEC | 1.89064679 |
| 22 | BCR | 1.81609588 |
| 23 | PDGFRA | 1.79852280 |
| 24 | TRIM28 | 1.79579072 |
| 25 | PTK2 | 1.72071163 |
| 26 | PLK3 | 1.70477965 |
| 27 | LATS1 | 1.61705820 |
| 28 | KIT | 1.55502934 |
| 29 | ZAK | 1.52622447 |
| 30 | LATS2 | 1.52322747 |
| 31 | PRKG2 | 1.49685989 |
| 32 | MAP3K14 | 1.41108858 |
| 33 | MKNK1 | 1.38378246 |
| 34 | VRK2 | 1.36250697 |
| 35 | MAP2K7 | 1.29486382 |
| 36 | YES1 | 1.28561444 |
| 37 | TLK1 | 1.27657950 |
| 38 | BLK | 1.24819243 |
| 39 | NTRK1 | 1.24249130 |
| 40 | SRPK1 | 1.22712904 |
| 41 | MAP3K12 | 1.22111548 |
| 42 | TSSK6 | 1.21783266 |
| 43 | PLK2 | 1.18678028 |
| 44 | STK3 | 1.16394008 |
| 45 | CDC7 | 1.13839819 |
| 46 | IRAK1 | 1.10867594 |
| 47 | PIK3CG | 1.09695508 |
| 48 | FLT3 | 1.09067098 |
| 49 | VRK1 | 1.07245274 |
| 50 | PLK1 | 1.05863269 |
| 51 | NEK9 | 1.02127878 |
| 52 | FES | 1.01553419 |
| 53 | BMPR1B | 1.00963262 |
| 54 | TGFBR1 | 1.00313539 |
| 55 | MATK | 0.98964273 |
| 56 | LIMK1 | 0.97570770 |
| 57 | ROCK2 | 0.97241924 |
| 58 | BRSK1 | 0.96421761 |
| 59 | ADRBK2 | 0.96179680 |
| 60 | IKBKB | 0.91636043 |
| 61 | PAK2 | 0.90403938 |
| 62 | MELK | 0.90101718 |
| 63 | FRK | 0.88053292 |
| 64 | MST4 | 0.87933377 |
| 65 | CSNK1A1L | 0.87314906 |
| 66 | SIK3 | 0.86080544 |
| 67 | TAF1 | 0.86022713 |
| 68 | WNK3 | 0.85874772 |
| 69 | TBK1 | 0.85846099 |
| 70 | CSNK1G3 | 0.85814496 |
| 71 | FER | 0.85347552 |
| 72 | IKBKE | 0.84593563 |
| 73 | IRAK2 | 0.83734902 |
| 74 | LMTK2 | 0.83177170 |
| 75 | STK39 | 0.82954100 |
| 76 | KDR | 0.82744576 |
| 77 | FGFR1 | 0.82379904 |
| 78 | EPHA3 | 0.81824974 |
| 79 | ILK | 0.80564292 |
| 80 | PLK4 | 0.80322259 |
| 81 | PNCK | 0.79441633 |
| 82 | ROCK1 | 0.76890624 |
| 83 | INSRR | 0.76614859 |
| 84 | CAMK1 | 0.75960919 |
| 85 | MYLK | 0.75760466 |
| 86 | TESK1 | 0.74164508 |
| 87 | ZAP70 | 0.74083648 |
| 88 | CSNK1G2 | 0.73751116 |
| 89 | MST1R | 0.73556628 |
| 90 | TXK | 0.71823018 |
| 91 | TRPM7 | 0.71667607 |
| 92 | BTK | 0.71074805 |
| 93 | BCKDK | 0.70720420 |
| 94 | JAK3 | 0.69328968 |
| 95 | MAPKAPK3 | 0.68934599 |
| 96 | AURKB | 0.66191892 |
| 97 | TGFBR2 | 0.65443569 |
| 98 | ABL2 | 0.65230343 |
| 99 | ERBB3 | 0.64819063 |
| 100 | NEK2 | 0.64649781 |
| 101 | PRPF4B | 0.64257291 |
| 102 | DMPK | 0.63395945 |
| 103 | CHEK2 | 0.62957943 |
| 104 | MAP3K11 | 0.62875530 |
| 105 | PIK3CA | 0.61750373 |
| 106 | RIPK4 | 0.59470719 |
| 107 | TIE1 | 0.56266662 |
| 108 | CDK8 | 0.55652714 |
| 109 | MAPK4 | 0.54392844 |
| 110 | PRKD3 | 0.53547811 |
| 111 | NUAK1 | 0.53400931 |
| 112 | TTN | 0.52922063 |
| 113 | MAPK13 | 0.52008031 |
| 114 | MOS | 0.51576962 |
| 115 | MAP2K3 | 0.51226136 |
| 116 | MAP2K6 | 0.49938762 |
| 117 | PRKD2 | 0.49201478 |
| 118 | BRSK2 | 0.48993369 |
| 119 | MAPKAPK5 | 0.46053279 |
| 120 | LYN | 0.45674190 |
| 121 | ACVR1B | 0.45420768 |
| 122 | CDK7 | 0.44744068 |
| 123 | TAOK2 | 0.43504082 |
| 124 | EIF2AK1 | 0.41988343 |
| 125 | STK10 | 0.41817914 |
| 126 | WEE1 | 0.39879257 |
| 127 | MAP3K1 | 0.39499142 |
| 128 | AKT2 | 0.38871626 |
| 129 | CDK9 | 0.38778994 |
| 130 | PDGFRB | 0.38727299 |
| 131 | CDK19 | 0.38361327 |
| 132 | STK4 | 0.37717195 |
| 133 | GSK3A | 0.37509945 |
| 134 | STK24 | 0.37242098 |
| 135 | BMPR2 | 0.36998378 |
| 136 | CAMK2D | 0.35128297 |
| 137 | SYK | 0.34866460 |
| 138 | AKT3 | 0.34559965 |
| 139 | TYK2 | 0.34327652 |
| 140 | PRKCD | 0.33584633 |
| 141 | PIM1 | 0.32993665 |
| 142 | ATM | 0.32706665 |
| 143 | MAP3K8 | 0.31766976 |
| 144 | GRK1 | 0.31036134 |
| 145 | LCK | 0.30509247 |
| 146 | CDK18 | 0.30236792 |
| 147 | MAP3K3 | 0.30234474 |
| 148 | EPHB2 | 0.29573443 |
| 149 | CAMKK1 | 0.27245760 |
| 150 | PBK | 0.26573017 |
| 151 | CSF1R | 0.25372367 |
| 152 | PRKCE | 0.22759497 |
| 153 | STK38L | 0.20492417 |
| 154 | ABL1 | 0.20409671 |
| 155 | DDR2 | 0.20341818 |
| 156 | CSNK1G1 | 0.20338613 |
| 157 | DYRK2 | 0.20261087 |
| 158 | MAP2K2 | 0.20150162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.42644723 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.66195194 |
| 3 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.48323393 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.44854314 |
| 5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.38779483 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.20547943 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.19068034 |
| 8 | Thyroid cancer_Homo sapiens_hsa05216 | 2.15283137 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.14467186 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09313279 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.04667488 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.04305738 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.02970961 |
| 14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.95567640 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 1.83397895 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.79975055 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.72342770 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.67141835 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.65970862 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65885694 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.63834888 |
| 22 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.57944252 |
| 23 | Adherens junction_Homo sapiens_hsa04520 | 1.54744702 |
| 24 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.53593084 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.52907588 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.52576187 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.50759195 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.49369707 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48447637 |
| 30 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.47499774 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.46718971 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46230289 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.45691092 |
| 34 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.44163556 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.41414685 |
| 36 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.41198889 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.40411453 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.39755322 |
| 39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.38098080 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.36682812 |
| 41 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.36365141 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36309357 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.31962041 |
| 44 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.28118624 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27805541 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26603843 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26253110 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26185244 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25966624 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 1.25067904 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.23092475 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.21539497 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 1.20070824 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.18779245 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.17395952 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16995066 |
| 57 | Tight junction_Homo sapiens_hsa04530 | 1.16735515 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14044489 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.13016642 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11945128 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 1.11502610 |
| 62 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.11292468 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10861292 |
| 64 | RNA transport_Homo sapiens_hsa03013 | 1.10153442 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10023194 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09501638 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06955025 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06933857 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06338558 |
| 70 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99991786 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99558125 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99348326 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98621663 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.98387969 |
| 75 | Base excision repair_Homo sapiens_hsa03410 | 0.98198817 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97805858 |
| 77 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96875946 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96410572 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95712929 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95593626 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95585243 |
| 82 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95276622 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94140182 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93942929 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.93749061 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93009439 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.92350076 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92224568 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87249272 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.87020912 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86861904 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.86000932 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.85530958 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84104043 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.83289039 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83189379 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83099639 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83089470 |
| 99 | Allograft rejection_Homo sapiens_hsa05330 | 0.82628259 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82488378 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.82138082 |
| 102 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.80531434 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80123847 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.80059516 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.79406950 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79035152 |
| 107 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76868948 |
| 108 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.76134690 |
| 109 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.75537434 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74007227 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73743122 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70665700 |
| 113 | Axon guidance_Homo sapiens_hsa04360 | 0.69640164 |
| 114 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68584486 |
| 115 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.68489251 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68264223 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68069476 |
| 118 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67394176 |
| 119 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65675835 |
| 120 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65212409 |
| 121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64285853 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64125128 |
| 123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63840355 |
| 124 | Spliceosome_Homo sapiens_hsa03040 | 0.63057608 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62068438 |
| 126 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61101009 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60488015 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.59605926 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.57542417 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57274690 |
| 131 | ABC transporters_Homo sapiens_hsa02010 | 0.56113433 |
| 132 | Tuberculosis_Homo sapiens_hsa05152 | 0.53980690 |
| 133 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53276015 |
| 134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53204199 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52764448 |
| 136 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52594427 |
| 137 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51585520 |
| 138 | RNA polymerase_Homo sapiens_hsa03020 | 0.51265998 |
| 139 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50750430 |
| 140 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50745301 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49731692 |
| 142 | Asthma_Homo sapiens_hsa05310 | 0.49443105 |
| 143 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48248857 |
| 144 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47584091 |
| 145 | Legionellosis_Homo sapiens_hsa05134 | 0.47177265 |
| 146 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46271977 |
| 147 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46086096 |
| 148 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.45478213 |
| 149 | Amoebiasis_Homo sapiens_hsa05146 | 0.45137371 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44483515 |
| 151 | Lysosome_Homo sapiens_hsa04142 | 0.43729042 |
| 152 | Mismatch repair_Homo sapiens_hsa03430 | 0.42211651 |
| 153 | Hepatitis C_Homo sapiens_hsa05160 | 0.40466877 |
| 154 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39453087 |
| 155 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38305835 |
| 156 | Influenza A_Homo sapiens_hsa05164 | 0.36622844 |

